ImmunityBio reports 3-year bladder preservation data for Anktiva plus BCG

October 16, 2026 11:49 AM

ImmunityBio, Inc. (NASDAQ: IBRX) announced the publication of long-term data from its Phase 2/3 QUILT-3.032 study in the Journal of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found